Additional file 1: of Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Oh, Chung; Kong, Sun-Young; Im, Hyeon-Su; Kim, Hwa; Kim, Min; Yoon, Kyong-Ah; Cho, Eun-Hae; Jang, Ja-Hyun; Lee, Junnam; Kang, Jihoon; Park, Sook; Ryoo, Baek-Yeol

doi:10.6084/m9.figshare.7936064.v1

12885_2019_5483_MOESM1_ESM.docx (172.34 kB)

Additional file 1: of Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

journal contribution

posted on 2019-04-01, 05:00 authored by Chung Oh, Sun-Young Kong, Hyeon-Su Im, Hwa Kim, Min Kim, Kyong-Ah Yoon, Eun-Hae Cho, Ja-Hyun Jang, Junnam Lee, Jihoon Kang, Sook Park, Baek-Yeol Ryoo

Figure S1. Scatter plot demonstrating the correlation of the I-score with the total cell-free DNA concentration. Figure S2. Kaplan-Meier curves for (A) time to progression and (B) overall survival according to the VEGFA ratio. Abbraviation: VEGFA, vascular endothelial growth factor-A. (DOCX172 Kb)